Anavex Life Sciences Corp (AVXL)

[Anshu2]

Sarepta PR’ed first results in June 2018, when it shot to $150 first time.

Then, it “failed” it’s P3 (functional endpoint/pivotal) trial in Jan 2020.

The restarted P3 trial will finish in a month.

AA is based on the “failed” 2020 trial and other biomarker/open-label/small trials.

So AA took 4.5 years. Full approval if the current trial succeeds will be in 6.5-7 years (note that part of the delay is due to a trial non-success).